Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A P Ford

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
British Journal of Pharmacology|July 1, 1997
Pharmacological pleiotropism of the human recombinant alpha1A-adrenoceptor: implications for alpha1-adrenoceptor classificationA P Ford, D V Daniels, D J Chang, et al.
Neurogastroenterology and Motility|September 29, 2001
ATP-gated ion channel P2X(3) is increased in human inflammatory bowel diseaseY Yiangou, P Facer, P A Baecker, et al.
Journal of the Autonomic Nervous System|June 28, 2000
Regulated expression of the rat recombinant P2X(3) receptor in stably transfected CHO-K1 tTA cellsW G Lachnit, I B Oglesby, J R Gever, et al.
BJU International|February 7, 2004
Endothelial nitric oxide synthase expression in neurogenic urinary bladders treated with intravesical resiniferatoxinA N Apostolidis, Y Yiangou, C M Brady, et al.
British Journal of Pharmacology|May 1, 1995
Functional evidence equating the pharmacologically-defined alpha 1A- and cloned alpha 1C-adrenoceptor: studies in the isolated perfused kidney of ratD R Blue, D W Bonhaus, A P Ford, et al.
European Journal of Pharmacology|May 20, 1999
Human cloned alpha1A-adrenoceptor isoforms display alpha1L-adrenoceptor pharmacology in functional studiesD V Daniels, J R Gever, J R Jasper, et al.
Nature|November 9, 2000
Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient miceD A Cockayne, S G Hamilton, Q M Zhu, et al.
Molecular Pharmacology|February 1, 1996
RS-17053 (N-[2-(2-cyclopropylmethoxyphenoxy)ethyl]-5-chloro-alpha, alpha-dimethyl-1H-indole-3-ethanamine hydrochloride), a selective alpha 1A-adrenoceptor antagonist, displays low affinity for functional alpha 1-adrenoceptors in human prostate: implications for adrenoceptor classificationA P Ford, N F Arredondo, D R Blue, et al.
British Journal of Pharmacology|June 16, 1999
In vitro alpha1-adrenoceptor pharmacology of Ro 70-0004 and RS-100329, novel alpha1A-adrenoceptor selective antagonistsT J Williams, D R Blue, D V Daniels, et al.
FEBS Letters|March 7, 1998
Molecular cloning, genomic characterization and expression of novel human alpha1A-adrenoceptor isoformsD J Chang, T K Chang, S S Yamanishi, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
British Journal of Pharmacology|July 1, 1997
Pharmacological pleiotropism of the human recombinant alpha1A-adrenoceptor: implications for alpha1-adrenoceptor classificationA P Ford, D V Daniels, D J Chang, et al.
Neurogastroenterology and Motility|September 29, 2001
ATP-gated ion channel P2X(3) is increased in human inflammatory bowel diseaseY Yiangou, P Facer, P A Baecker, et al.
Journal of the Autonomic Nervous System|June 28, 2000
Regulated expression of the rat recombinant P2X(3) receptor in stably transfected CHO-K1 tTA cellsW G Lachnit, I B Oglesby, J R Gever, et al.
BJU International|February 7, 2004
Endothelial nitric oxide synthase expression in neurogenic urinary bladders treated with intravesical resiniferatoxinA N Apostolidis, Y Yiangou, C M Brady, et al.
British Journal of Pharmacology|May 1, 1995
Functional evidence equating the pharmacologically-defined alpha 1A- and cloned alpha 1C-adrenoceptor: studies in the isolated perfused kidney of ratD R Blue, D W Bonhaus, A P Ford, et al.
European Journal of Pharmacology|May 20, 1999
Human cloned alpha1A-adrenoceptor isoforms display alpha1L-adrenoceptor pharmacology in functional studiesD V Daniels, J R Gever, J R Jasper, et al.
Nature|November 9, 2000
Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient miceD A Cockayne, S G Hamilton, Q M Zhu, et al.
Molecular Pharmacology|February 1, 1996
RS-17053 (N-[2-(2-cyclopropylmethoxyphenoxy)ethyl]-5-chloro-alpha, alpha-dimethyl-1H-indole-3-ethanamine hydrochloride), a selective alpha 1A-adrenoceptor antagonist, displays low affinity for functional alpha 1-adrenoceptors in human prostate: implications for adrenoceptor classificationA P Ford, N F Arredondo, D R Blue, et al.
British Journal of Pharmacology|June 16, 1999
In vitro alpha1-adrenoceptor pharmacology of Ro 70-0004 and RS-100329, novel alpha1A-adrenoceptor selective antagonistsT J Williams, D R Blue, D V Daniels, et al.
FEBS Letters|March 7, 1998
Molecular cloning, genomic characterization and expression of novel human alpha1A-adrenoceptor isoformsD J Chang, T K Chang, S S Yamanishi, et al.
Pageof 5